Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New ERAP1 inhibitors identified at Grey Wolf Therapeutics

June 8, 2021

Chengdu Baiyu Pharmaceutical divulges NLRP3 inflammasome inhibitors

June 8, 2021

Results presented from FIH study of RBN-2397 in patients with advanced solid tumors

June 8, 2021

Initial first-in-human data presented for TNO-155

June 7, 2021

New phase I/II study evaluates AGuIX gadolinium-based nanoparticles in pancreatic and lung cancers

June 7, 2021

Enrollment begins in phase I study of RO-7300490 as single agent or in combination with atezolizumab

June 7, 2021

Taisho Pharmaceutical presents new MMP-2 inhibitors

June 7, 2021

New ROCK1/2 inhibitors identified at Wuhan LL Science and Technology Development Co.

June 7, 2021

Wuhan Optics Valley Yatai Pharmaceutical Research Institute patents HIF-2-alpha inhibitors

June 7, 2021

Betta Pharmaceuticals patents PI3K inhibitors

June 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...